The 10-K against last year's
686 changes: 402 added, 275 removed, 9 reworded
10-K 0001628280-26-019879 (2026-03-19) vs 10-K 0001213900-25-026431 (2025-03-31) Not compared: Legal Proceedings, Accounting Policies.
The redline
The paragraph that changed most in each section
Marked against last year's 10-K:
cut words struck through, new words highlighted and underlined.
MD&A 190 words changed in this paragraph; it is 30% similar to last year's version.
On September 27, 2024, 15, 2025, the Company entered into the ATM ASST Sales Agreement with the ASST Sales Agent. Under Agent, pursuant to which the terms of the ATM Sales Agreement, the Company may, Company, from time to time, in transactions that are deemed to be “at the market offerings” as defined in Rule 415 under the Securities Act, issue at its option, may offer and sell shares of its Class A Common Stock to or through or to the ASST Sales Agent, initially acting as the principal and/or the sole agent, having an aggregate sales price of up to $450.0 million. During the period from September 12, 2025 to December 31, 2025, the Company issued 26.4 million shares (1.3 million on a maximum aggregate amount split-adjusted basis) of $2,271,487 of shares of the Company’s Class B A Common Stock (the “ATM Shares”). The for aggregate gross proceeds of $78.7 million. As of December 31, 2025, the Company has the availability to raise approximately $371.3 million through the issuance and sale of the ATM Shares to or through the Sales Agent from time to time will be effected its Class A Common Stock pursuant to the Shelf Registration Statement and the prospectus supplements filed by the Company with the SEC on September 30, 2024 and November 18, 2024 relating to the offering of the ATM Shares and the accompanying base prospectus. ASST Sales Agreement.
Source: Item 7, 10-K 0001628280-26-019879 vs Item 7, 10-K 0001213900-25-026431
Risk Factors 151 words changed in this paragraph; it is 35% similar to last year's version.
The trading market for our Class B Common Stock will depend in part on securities may be influenced by the research and reports that securities or industry analysts publish about us or our business. business, market or competitors. We will not have any control over these analysts. If research securities and industry analysts do not establish and maintain adequate research cover our company, cease coverage of our company, downgrade our securities, or if one or more of the analysts who covers us downgrades our Class B Common Stock or publishes publish inaccurate or unfavorable research about our business, the market price for our Class B Common Stock would likely decline. If one or more of these analysts cease coverage of our company or fail to publish reports on us regularly, we could lose visibility in the financial markets, which, in turn, could cause the market price or and trading volume for our Class B Common Stock securities may be negatively affected. In light of the unpredictability inherent in our anticipated businesses, our financial outlook commentary may differ from analysts’ expectations, which could cause volatility to decline. the price of our securities.
Source: Item 1A, 10-K 0001628280-26-019879 vs Item 1A, 10-K 0001213900-25-026431
Every change, by type
Sentences and paragraphs added, removed or reworded
Sentences and paragraphs of ASST's Risk Factors and MD&A, 10-K 2026-03-19 against 10-K 2025-03-31. Each links to the text at sec.gov.
RewordedRisk Factors
RewordedRisk Factors
In that event, such case, the market price of our shares Class A Common Stock and our SATA Stock, which we refer to collectively as our “listed securities,” could decline, and you could may lose all or part of your investment.
RewordedRisk Factors
We have a limited operating history, which may make history and recently launched a bitcoin treasury strategy, making it difficult to evaluate our business and prospects. prospects and may increase the risks associated with any investment.
RewordedRisk Factors
If securities or industry analysts do not publish research or cease publishing research, or publish inaccurate or unfavorable research research, about our business, the market price for the shares of our Class A Common Stock and trading volume its liquidity could decline.
RewordedRisk Factors
The trading market for our Class B Common Stock will depend in part on securities may be influenced by the research and reports that securities or industry analysts publish about us or our business. business, market or competitors.
RewordedRisk Factors
If any of the following events risks occur, our business, financial condition, business and or results of operations (including cash flows) may could be materially adversely affected.
RewordedRisk Factors
In addition, Section 107 of the JOBS Act also provides that an emerging growth company can take advantage of utilize the extended transition period provided in Section 7(a)(2)(B) of the Securities Act Act, for complying with new or revised accounting standards.
RewordedMD&A
Show the other 1
RewordedMD&A
Actual results may and outcomes could differ from these estimates under different assumptions or conditions. and assumptions.